Glucose/fructose/phosphoric acid
Combination of | |
---|---|
Glucose | Monosaccharide |
Fructose | Monosaccharide |
Phosphoric acid | Acid |
Clinical data | |
Trade names | Emetrol |
AHFS/Drugs.com | Consumer Drug Information |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Glucose/fructose/phosphoric acid (trade name Emetrol) is an over-the-counter antiemetic taken to relieve nausea and vomiting. Made by WellSpring Pharmaceutical Corporation, it was formerly distributed by McNeil Consumer Healthcare.
History
Emetrol was created by Kinney and Company of Columbus, Indiana and was first used in 1949.[1]
It is a phosphorated carbohydrate solution, and comes in syrup form.
Contraindications
Since Emetrol contains fructose it is contraindicated for people with hereditary fructose intolerance (HFI). In diabetes patients, it can cause potentially harmful hyperglycaemia (high blood sugar).[2]
References
External links
This article is issued from Wikipedia - version of the 8/1/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.